A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session33f20025f42e95408c3662e6337f045a8a3eb7c8): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Foot and Mouth Disease (FMD) Vaccine Market Research Report 2024

img

Global Foot and Mouth Disease (FMD) Vaccine Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Foot and Mouth Disease (FMD) Vaccine Market Research Report 2024

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.
According to MRAResearch’s new survey, global Foot and Mouth Disease (FMD) Vaccine market is projected to reach US$ 1346.8 million in 2033, increasing from US$ 1046 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Foot and Mouth Disease (FMD) Vaccine market research.
Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.
Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.
In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Foot and Mouth Disease (FMD) Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Agrovet market
Biogenesis Bago
Vecol
FGBI - Federal Centre for Animal Health
Indian Immunologicals
Merial
VSVRI
FMD Center
Limor de Colombia
Segment by Type
Conventional Vaccines
Emergency Vaccines

Segment by Application


Hospital
Clinic
Other

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Foot and Mouth Disease (FMD) Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Foot and Mouth Disease (FMD) Vaccine Market Overview
1.1 Product Overview and Scope of Foot and Mouth Disease (FMD) Vaccine
1.2 Foot and Mouth Disease (FMD) Vaccine Segment by Type
1.2.1 Global Foot and Mouth Disease (FMD) Vaccine Market Value Comparison by Type (2023-2033)
1.2.2 Conventional Vaccines
1.2.3 Emergency Vaccines
1.3 Foot and Mouth Disease (FMD) Vaccine Segment by Application
1.3.1 Global Foot and Mouth Disease (FMD) Vaccine Market Value by Application: (2023-2033)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Foot and Mouth Disease (FMD) Vaccine Market Size Estimates and Forecasts
1.4.1 Global Foot and Mouth Disease (FMD) Vaccine Revenue 2018-2033
1.4.2 Global Foot and Mouth Disease (FMD) Vaccine Sales 2018-2033
1.4.3 Global Foot and Mouth Disease (FMD) Vaccine Market Average Price (2018-2033)
1.5 Assumptions and Limitations
2 Foot and Mouth Disease (FMD) Vaccine Market Competition by Manufacturers
2.1 Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Foot and Mouth Disease (FMD) Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Foot and Mouth Disease (FMD) Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccine, Product Type & Application
2.7 Foot and Mouth Disease (FMD) Vaccine Market Competitive Situation and Trends
2.7.1 Foot and Mouth Disease (FMD) Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Foot and Mouth Disease (FMD) Vaccine Players Market Share by Revenue
2.7.3 Global Foot and Mouth Disease (FMD) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Foot and Mouth Disease (FMD) Vaccine Retrospective Market Scenario by Region
3.1 Global Foot and Mouth Disease (FMD) Vaccine Market Size by Region: 2018 Versus 2022 Versus 2033
3.2 Global Foot and Mouth Disease (FMD) Vaccine Global Foot and Mouth Disease (FMD) Vaccine Sales by Region: 2018-2033
3.2.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Region: 2018-2023
3.2.2 Global Foot and Mouth Disease (FMD) Vaccine Sales by Region: 2024-2033
3.3 Global Foot and Mouth Disease (FMD) Vaccine Global Foot and Mouth Disease (FMD) Vaccine Revenue by Region: 2018-2033
3.3.1 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Region: 2018-2023
3.3.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Region: 2024-2033
3.4 North America Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Country
3.4.1 North America Foot and Mouth Disease (FMD) Vaccine Market Size by Country: 2018 VS 2022 VS 2033
3.4.2 North America Foot and Mouth Disease (FMD) Vaccine Sales by Country (2018-2033)
3.4.3 North America Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2018-2033)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Country
3.5.1 Europe Foot and Mouth Disease (FMD) Vaccine Market Size by Country: 2018 VS 2022 VS 2033
3.5.2 Europe Foot and Mouth Disease (FMD) Vaccine Sales by Country (2018-2033)
3.5.3 Europe Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2018-2033)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Market Size by Country: 2018 VS 2022 VS 2033
3.6.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales by Country (2018-2033)
3.6.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2018-2033)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Country
3.7.1 Latin America Foot and Mouth Disease (FMD) Vaccine Market Size by Country: 2018 VS 2022 VS 2033
3.7.2 Latin America Foot and Mouth Disease (FMD) Vaccine Sales by Country (2018-2033)
3.7.3 Latin America Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2018-2033)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Market Size by Country: 2018 VS 2022 VS 2033
3.8.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales by Country (2018-2033)
3.8.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2018-2033)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Type (2018-2033)
4.1.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Type (2018-2023)
4.1.2 Global Foot and Mouth Disease (FMD) Vaccine Sales by Type (2024-2033)
4.1.3 Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Type (2018-2033)
4.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Type (2018-2033)
4.2.1 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Type (2018-2023)
4.2.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Type (2024-2033)
4.2.3 Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Type (2018-2033)
4.3 Global Foot and Mouth Disease (FMD) Vaccine Price by Type (2018-2033)
5 Segment by Application
5.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Application (2018-2033)
5.1.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Application (2018-2023)
5.1.2 Global Foot and Mouth Disease (FMD) Vaccine Sales by Application (2024-2033)
5.1.3 Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Application (2018-2033)
5.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Application (2018-2033)
5.2.1 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Application (2018-2023)
5.2.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Application (2024-2033)
5.2.3 Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Application (2018-2033)
5.3 Global Foot and Mouth Disease (FMD) Vaccine Price by Application (2018-2033)
6 Key Companies Profiled
6.1 Agrovet market
6.1.1 Agrovet market Corporation Information
6.1.2 Agrovet market Description and Business Overview
6.1.3 Agrovet market Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Agrovet market Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.1.5 Agrovet market Recent Developments/Updates
6.2 Biogenesis Bago
6.2.1 Biogenesis Bago Corporation Information
6.2.2 Biogenesis Bago Description and Business Overview
6.2.3 Biogenesis Bago Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Biogenesis Bago Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.2.5 Biogenesis Bago Recent Developments/Updates
6.3 Vecol
6.3.1 Vecol Corporation Information
6.3.2 Vecol Description and Business Overview
6.3.3 Vecol Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Vecol Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.3.5 Vecol Recent Developments/Updates
6.4 FGBI - Federal Centre for Animal Health
6.4.1 FGBI - Federal Centre for Animal Health Corporation Information
6.4.2 FGBI - Federal Centre for Animal Health Description and Business Overview
6.4.3 FGBI - Federal Centre for Animal Health Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 FGBI - Federal Centre for Animal Health Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.4.5 FGBI - Federal Centre for Animal Health Recent Developments/Updates
6.5 Indian Immunologicals
6.5.1 Indian Immunologicals Corporation Information
6.5.2 Indian Immunologicals Description and Business Overview
6.5.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.5.5 Indian Immunologicals Recent Developments/Updates
6.6 Merial
6.6.1 Merial Corporation Information
6.6.2 Merial Description and Business Overview
6.6.3 Merial Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merial Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.6.5 Merial Recent Developments/Updates
6.7 VSVRI
6.6.1 VSVRI Corporation Information
6.6.2 VSVRI Description and Business Overview
6.6.3 VSVRI Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 VSVRI Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.7.5 VSVRI Recent Developments/Updates
6.8 FMD Center
6.8.1 FMD Center Corporation Information
6.8.2 FMD Center Description and Business Overview
6.8.3 FMD Center Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 FMD Center Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.8.5 FMD Center Recent Developments/Updates
6.9 Limor de Colombia
6.9.1 Limor de Colombia Corporation Information
6.9.2 Limor de Colombia Description and Business Overview
6.9.3 Limor de Colombia Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Limor de Colombia Foot and Mouth Disease (FMD) Vaccine Product Portfolio
6.9.5 Limor de Colombia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Foot and Mouth Disease (FMD) Vaccine Industry Chain Analysis
7.2 Foot and Mouth Disease (FMD) Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Foot and Mouth Disease (FMD) Vaccine Production Mode & Process
7.4 Foot and Mouth Disease (FMD) Vaccine Sales and Marketing
7.4.1 Foot and Mouth Disease (FMD) Vaccine Sales Channels
7.4.2 Foot and Mouth Disease (FMD) Vaccine Distributors
7.5 Foot and Mouth Disease (FMD) Vaccine Customers
8 Foot and Mouth Disease (FMD) Vaccine Market Dynamics
8.1 Foot and Mouth Disease (FMD) Vaccine Industry Trends
8.2 Foot and Mouth Disease (FMD) Vaccine Market Drivers
8.3 Foot and Mouth Disease (FMD) Vaccine Market Challenges
8.4 Foot and Mouth Disease (FMD) Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Foot and Mouth Disease (FMD) Vaccine Market Value Comparison by Type (2023-2033) & (US$ Million)
Table 2. Global Foot and Mouth Disease (FMD) Vaccine Market Value Comparison by Application (2023-2033) & (US$ Million)
Table 3. Global Foot and Mouth Disease (FMD) Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Foot and Mouth Disease (FMD) Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Foot and Mouth Disease (FMD) Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Foot and Mouth Disease (FMD) Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Foot and Mouth Disease (FMD) Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Foot and Mouth Disease (FMD) Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Foot and Mouth Disease (FMD) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Foot and Mouth Disease (FMD) Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Foot and Mouth Disease (FMD) Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 17. Global Foot and Mouth Disease (FMD) Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Foot and Mouth Disease (FMD) Vaccine Sales by Region (2024-2033) & (K Units)
Table 20. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Region (2024-2033)
Table 21. Global Foot and Mouth Disease (FMD) Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Foot and Mouth Disease (FMD) Vaccine Revenue by Region (2024-2033) & (US$ Million)
Table 24. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Region (2024-2033)
Table 25. North America Foot and Mouth Disease (FMD) Vaccine Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 26. North America Foot and Mouth Disease (FMD) Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America Foot and Mouth Disease (FMD) Vaccine Sales by Country (2024-2033) & (K Units)
Table 28. North America Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2024-2033) & (US$ Million)
Table 30. Europe Foot and Mouth Disease (FMD) Vaccine Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 31. Europe Foot and Mouth Disease (FMD) Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Foot and Mouth Disease (FMD) Vaccine Sales by Country (2024-2033) & (K Units)
Table 33. Europe Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2024-2033) & (US$ Million)
Table 35. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 36. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales by Region (2024-2033) & (K Units)
Table 38. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue by Region (2024-2033) & (US$ Million)
Table 40. Latin America Foot and Mouth Disease (FMD) Vaccine Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 41. Latin America Foot and Mouth Disease (FMD) Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Foot and Mouth Disease (FMD) Vaccine Sales by Country (2024-2033) & (K Units)
Table 43. Latin America Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Foot and Mouth Disease (FMD) Vaccine Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 46. Middle East & Africa Foot and Mouth Disease (FMD) Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Foot and Mouth Disease (FMD) Vaccine Sales by Country (2024-2033) & (K Units)
Table 48. Middle East & Africa Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2024-2033) & (US$ Million)
Table 50. Global Foot and Mouth Disease (FMD) Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global Foot and Mouth Disease (FMD) Vaccine Sales (K Units) by Type (2024-2033)
Table 52. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Type (2024-2033)
Table 54. Global Foot and Mouth Disease (FMD) Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Foot and Mouth Disease (FMD) Vaccine Revenue (US$ Million) by Type (2024-2033)
Table 56. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Type (2024-2033)
Table 58. Global Foot and Mouth Disease (FMD) Vaccine Price (USD/Unit) by Type (2018-2023)
Table 59. Global Foot and Mouth Disease (FMD) Vaccine Price (USD/Unit) by Type (2024-2033)
Table 60. Global Foot and Mouth Disease (FMD) Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global Foot and Mouth Disease (FMD) Vaccine Sales (K Units) by Application (2024-2033)
Table 62. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Application (2024-2033)
Table 64. Global Foot and Mouth Disease (FMD) Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Foot and Mouth Disease (FMD) Vaccine Revenue (US$ Million) by Application (2024-2033)
Table 66. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Application (2024-2033)
Table 68. Global Foot and Mouth Disease (FMD) Vaccine Price (USD/Unit) by Application (2018-2023)
Table 69. Global Foot and Mouth Disease (FMD) Vaccine Price (USD/Unit) by Application (2024-2033)
Table 70. Agrovet market Corporation Information
Table 71. Agrovet market Description and Business Overview
Table 72. Agrovet market Foot and Mouth Disease (FMD) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Agrovet market Foot and Mouth Disease (FMD) Vaccine Product
Table 74. Agrovet market Recent Developments/Updates
Table 75. Biogenesis Bago Corporation Information
Table 76. Biogenesis Bago Description and Business Overview
Table 77. Biogenesis Bago Foot and Mouth Disease (FMD) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Biogenesis Bago Foot and Mouth Disease (FMD) Vaccine Product
Table 79. Biogenesis Bago Recent Developments/Updates
Table 80. Vecol Corporation Information
Table 81. Vecol Description and Business Overview
Table 82. Vecol Foot and Mouth Disease (FMD) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Vecol Foot and Mouth Disease (FMD) Vaccine Product
Table 84. Vecol Recent Developments/Updates
Table 85. FGBI - Federal Centre for Animal Health Corporation Information
Table 86. FGBI - Federal Centre for Animal Health Description and Business Overview
Table 87. FGBI - Federal Centre for Animal Health Foot and Mouth Disease (FMD) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. FGBI - Federal Centre for Animal Health Foot and Mouth Disease (FMD) Vaccine Product
Table 89. FGBI - Federal Centre for Animal Health Recent Developments/Updates
Table 90. Indian Immunologicals Corporation Information
Table 91. Indian Immunologicals Description and Business Overview
Table 92. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccine Product
Table 94. Indian Immunologicals Recent Developments/Updates
Table 95. Merial Corporation Information
Table 96. Merial Description and Business Overview
Table 97. Merial Foot and Mouth Disease (FMD) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Merial Foot and Mouth Disease (FMD) Vaccine Product
Table 99. Merial Recent Developments/Updates
Table 100. VSVRI Corporation Information
Table 101. VSVRI Description and Business Overview
Table 102. VSVRI Foot and Mouth Disease (FMD) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. VSVRI Foot and Mouth Disease (FMD) Vaccine Product
Table 104. VSVRI Recent Developments/Updates
Table 105. FMD Center Corporation Information
Table 106. FMD Center Description and Business Overview
Table 107. FMD Center Foot and Mouth Disease (FMD) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. FMD Center Foot and Mouth Disease (FMD) Vaccine Product
Table 109. FMD Center Recent Developments/Updates
Table 110. Limor de Colombia Corporation Information
Table 111. Limor de Colombia Description and Business Overview
Table 112. Limor de Colombia Foot and Mouth Disease (FMD) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Limor de Colombia Foot and Mouth Disease (FMD) Vaccine Product
Table 114. Limor de Colombia Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Foot and Mouth Disease (FMD) Vaccine Distributors List
Table 118. Foot and Mouth Disease (FMD) Vaccine Customers List
Table 119. Foot and Mouth Disease (FMD) Vaccine Market Trends
Table 120. Foot and Mouth Disease (FMD) Vaccine Market Drivers
Table 121. Foot and Mouth Disease (FMD) Vaccine Market Challenges
Table 122. Foot and Mouth Disease (FMD) Vaccine Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Foot and Mouth Disease (FMD) Vaccine
Figure 2. Global Foot and Mouth Disease (FMD) Vaccine Market Value Comparison by Type (2023-2033) & (US$ Million)
Figure 3. Global Foot and Mouth Disease (FMD) Vaccine Market Share by Type in 2022 & 2033
Figure 4. Conventional Vaccines Product Picture
Figure 5. Emergency Vaccines Product Picture
Figure 6. Global Foot and Mouth Disease (FMD) Vaccine Market Value Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Foot and Mouth Disease (FMD) Vaccine Market Share by Application in 2022 & 2033
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Foot and Mouth Disease (FMD) Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Foot and Mouth Disease (FMD) Vaccine Market Size (2018-2033) & (US$ Million)
Figure 13. Global Foot and Mouth Disease (FMD) Vaccine Sales (2018-2033) & (K Units)
Figure 14. Global Foot and Mouth Disease (FMD) Vaccine Average Price (USD/Unit) & (2018-2033)
Figure 15. Foot and Mouth Disease (FMD) Vaccine Report Years Considered
Figure 16. Foot and Mouth Disease (FMD) Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global Foot and Mouth Disease (FMD) Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Foot and Mouth Disease (FMD) Vaccine Players: Market Share by Revenue in 2022
Figure 19. Foot and Mouth Disease (FMD) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Foot and Mouth Disease (FMD) Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Figure 21. North America Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Country (2018-2033)
Figure 22. North America Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Country (2018-2033)
Figure 23. U.S. Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 24. Canada Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 25. Europe Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Country (2018-2033)
Figure 26. Europe Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Country (2018-2033)
Figure 27. Germany Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 28. France Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 29. U.K. Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 30. Italy Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 31. Russia Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 32. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Region (2018-2033)
Figure 33. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Region (2018-2033)
Figure 34. China Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 35. Japan Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 36. South Korea Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 37. India Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 38. Australia Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 39. Taiwan Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 40. Indonesia Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 41. Thailand Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 42. Malaysia Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 43. Philippines Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 44. Latin America Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Country (2018-2033)
Figure 45. Latin America Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Country (2018-2033)
Figure 46. Mexico Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 47. Brazil Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 48. Argentina Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Country (2018-2033)
Figure 50. Middle East & Africa Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Country (2018-2033)
Figure 51. Turkey Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 53. UAE Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 54. Global Sales Market Share of Foot and Mouth Disease (FMD) Vaccine by Type (2018-2033)
Figure 55. Global Revenue Market Share of Foot and Mouth Disease (FMD) Vaccine by Type (2018-2033)
Figure 56. Global Foot and Mouth Disease (FMD) Vaccine Price (USD/Unit) by Type (2018-2033)
Figure 57. Global Sales Market Share of Foot and Mouth Disease (FMD) Vaccine by Application (2018-2033)
Figure 58. Global Revenue Market Share of Foot and Mouth Disease (FMD) Vaccine by Application (2018-2033)
Figure 59. Global Foot and Mouth Disease (FMD) Vaccine Price (USD/Unit) by Application (2018-2033)
Figure 60. Foot and Mouth Disease (FMD) Vaccine Value Chain
Figure 61. Foot and Mouth Disease (FMD) Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries